Literature DB >> 3345953

Pelvic lymphocyst--a 10-year experience.

A Ilancheran1, J M Monaghan.   

Abstract

Pelvic lymphocysts occur infrequently after radical surgery for cervical cancer. The problem is one of recognition. In a retrospective analysis of patients seen over 10 years in this department, the incidence was 25.3%. All were diagnosed by bimanual, clinical examination only. The only factor that appears to relate to the formation of lymphocysts is the presence of poorly differentiated tumors; 70.8% of patients developing lymphocysts had poorly differentiated tumors. All the lymphocysts in this series resolved spontaneously and did not produce any major complications.

Entities:  

Mesh:

Year:  1988        PMID: 3345953     DOI: 10.1016/0090-8258(88)90232-6

Source DB:  PubMed          Journal:  Gynecol Oncol        ISSN: 0090-8258            Impact factor:   5.482


  10 in total

1.  An analysis of the risk factors and management of lymphocele after pelvic lymphadenectomy in patients with gynecologic malignancies.

Authors:  Hee Yeon Kim; Jae Wook Kim; Sung Hoon Kim; Young Tae Kim; Jae Hoon Kim
Journal:  Cancer Res Treat       Date:  2004-12-31       Impact factor: 4.679

Review 2.  Lymphocele.

Authors:  K S Metcalf; K R Peel
Journal:  Ann R Coll Surg Engl       Date:  1993-11       Impact factor: 1.891

3.  Robot-assisted removal of a lymphocyst causing severe neuralgic pain and adductor atrophy.

Authors:  Giorgio Cazzaniga; Christer Borgfeldt; Nils-Olof Wallengren; Jan Persson
Journal:  J Robot Surg       Date:  2011-04-24

4.  Lower-limb drainage mapping for lymphedema risk reduction after pelvic lymphadenectomy for endometrial cancer.

Authors:  Anne-Sophie Bats; Claude Nos; Chérazade Bensaïd; Marie-Aude Le Frère-Belda; Marie-Anne Collignon; Marc Faraggi; Fabrice Lécuru
Journal:  Oncologist       Date:  2013-01-18

Review 5.  Retroperitoneal drainage versus no drainage after pelvic lymphadenectomy for the prevention of lymphocyst formation in patients with gynaecological malignancies.

Authors:  Kittipat Charoenkwan; Chumnan Kietpeerakool
Journal:  Cochrane Database Syst Rev       Date:  2014-06-04

6.  Prevention of lymphocele development in gynecologic cancers by the electrothermal bipolar vessel sealing device.

Authors:  Naotake Tsuda; Kimio Ushijima; Kouichiro Kawano; Shuji Takemoto; Shin Nishio; Gounosuke Sonoda; Toshiharu Kamura
Journal:  J Gynecol Oncol       Date:  2014-07-03       Impact factor: 4.401

7.  Risk factors, microbiology and management of infected lymphocyst after lymphadenectomy for gynecologic malignancies.

Authors:  Xuegong Ma; Yingmei Wang; Aiping Fan; Mengting Dong; Xin Zhao; Xuhong Zhang; Fengxia Xue
Journal:  Arch Gynecol Obstet       Date:  2018-09-29       Impact factor: 2.344

8.  Development of prediction models for lymph node metastasis in endometrioid endometrial carcinoma.

Authors:  Hege F Berg; Zhenlin Ju; Madeleine Myrvold; Kristine E Fasmer; Mari K Halle; Erling A Hoivik; Shannon N Westin; Jone Trovik; Ingfrid S Haldorsen; Gordon B Mills; Camilla Krakstad; Henrica M J Werner
Journal:  Br J Cancer       Date:  2020-02-10       Impact factor: 7.640

9.  Risk factors for lower limb lymphedema after lymph node dissection in patients with ovarian and uterine carcinoma.

Authors:  Harue Tada; Satoshi Teramukai; Masanori Fukushima; Hiroshi Sasaki
Journal:  BMC Cancer       Date:  2009-02-05       Impact factor: 4.430

10.  Treatment of lymphocele with negative pressure wound therapy post inguinal mass excision: A case-report.

Authors:  Caio Cesar Martins Focássio; Ricardo Augusto Bravo Gamboa; Luis Felipe Staut de Marco; Daniela Mina Fukasawa; Talita da Silva Parente; Vitor Leoni Boher Lopes Dornas
Journal:  Int J Surg Case Rep       Date:  2019-11-19
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.